EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Serological and Molecular Epidemiology of Hepatitis B, C, and D Viruses in Northwest Russia: A Population-Based Cross-Sectional Study

Anna Y Popova, Yulia V Ostankova iD, Alesia Y Olkhovskaya, Olga A Petrova, Alexandr N Shchemelev iD, Elena N Serikova, Svetlana A Egorova iD, Diana E Reingardt iD, Irina V Drozd, Ojuna B Zhimbaeva iD, Ekaterina M Danilova, Angelica M Milichkina und 6 weitere

Viruses · 30.05.2026 · 18 (6) · 632

DOI: 10.3390/v18060632 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Viruses, online erschienen am 30.05.2026. Verfasst von Anna Y Popova und 17 weiteren Autor:innen. Beteiligte Einrichtung: Federal Service for the Oversight of Consumer Protection and Welfare, 127994 Moscow, Russia. Hauptthemen laut MEDLINE: Hepatitis D, Hepatitis B, Hepatitis C, Hepatitis Delta Virus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hepatitis B (HBV), C (HCV), and D (HDV) viruses remain a major public health burden. Occult HBV infection (OBI) represents a hidden reservoir with clinical and epidemiological significance, yet its prevalence in Northwest Russia is unknown. We aimed to comprehensively assess the serological and molecular epidemiology of HBV, HCV, and HDV in St. Petersburg and the Leningrad region.

Methods

In this cross-sectional study, 6773 apparently healthy volunteers were enrolled. Plasma samples were tested for hepatitis B surface antigen (HBsAg), antibodies to HBV core antigen (anti-HBc), antibodies to HBsAg (anti-HBs), antibodies to HCV (anti-HCV), and antibodies to HDV (anti-HDV) by ELISA. All anti-HCV- and anti-HDV-positive samples were tested for HCV RNA and HDV RNA by real-time PCR. All samples were tested for HBV DNA using a highly sensitive in-house nested real-time PCR assay (detection limit: 5 IU/mL). All “HBV DNA-positive, HBsAg-negative” cases confirmed by two independent extractions were classified as OBI. Vaccination status, self-reported history, and iatrogenic interventions were recorded.

Results

Overall seroprevalence values were: HBsAg 1.7%; anti-HBc 11.3%; anti-HBs 43.0%; anti-HCV 1.9%; and anti-HDV 0.6%. Anti-HBc increased sharply with age (3.1% in children to 26.4% in the elderly, p < 0.0001), while anti-HBs declined (69.9% to 29.8%, p < 0.0001). HBV DNA was detected in 118 participants (1.7%). Of these, only 73 individuals (1.1%) were HBsAg-positive, while the remaining 45 participants (0.7%) had undetectable HBsAg, meeting the criteria for OBI. OBI was detected across all age groups, including children. Serological profiling of OBI cases revealed that 57.8% lacked both anti-HBc and anti-HBs, 35.6% had isolated anti-HBs, 2.2% had isolated anti-HBc, and 4.4% had both antibodies. HCV RNA was detected in 15.0% of anti-HCV-positive individuals (all adults). No HDV RNA was detected. Self-reported history underestimated true infection rates: 1.4% of those denying HBV infection were HBsAg-positive and 10.6% were anti-HBc-positive. Among those denying HCV infection, 1.4% were anti-HCV-positive. Vaccination coverage was 70.8%, declining from 90.9% in children to 39.0% in the elderly (p < 0.0001). Among vaccinated individuals, 48.0% lacked protective anti-HBs (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis DHepatitis BHepatitis CHepatitis Delta VirusHepacivirusHepatitis B virusHumansCross-Sectional StudiesRussiaMaleFemaleAdultMolecular EpidemiologyMiddle AgedAdolescentYoung AdultHepatitis B Surface AntigensChildAgedSeroepidemiologic StudiesHepatitis AntibodiesChild, PreschoolDNA, ViralHepatitis B AntibodiesHepatitis C AntibodiesRNA, Viral

Stichwörter der Autor:innen

Russiahepatitis B virus (HBV)hepatitis C virus (HCV)hepatitis delta virus (HDV)iatrogenic transmissionmolecular epidemiologyoccult HBV infection (OBI)seroprevalencevaccination coveragevaccine-induced immunity

Substanzen

Hepatitis B Surface AntigensHepatitis AntibodiesDNA, ViralHepatitis B AntibodiesHepatitis C AntibodiesRNA, Viral

Autor:innen und Institutionen

  • Federal Service for the Oversight of Consumer Protection and Welfare, 127994 Moscow, Russia.
  • Saint Petersburg Pasteur Institute, 197101 St. Petersburg, Russia.
  • Federal Service for the Oversight of Consumer Protection and Welfare, 192029 St. Petersburg and Leningrad Region, Russia.

ORCID-Profile: Yulia V Ostankova, Alexandr N Shchemelev, Svetlana A Egorova, Diana E Reingardt, Ojuna B Zhimbaeva, Edward S Ramsay, Areg A Totolian

Zitieren

APA

Popova, A. Y., Ostankova, Y. V., Olkhovskaya, A. Y., Petrova, O. A., Shchemelev, A. N., Serikova, E. N., Egorova, S. A., Reingardt, D. E., Drozd, I. V., Zhimbaeva, O. B., Danilova, E. M., Milichkina, A. M., Ezhlova, E. B., Melnikova, A. A., Bashketova, N. S., Buts, L. V., Ramsay, E. S., & Totolian, A. A. (2026). Serological and Molecular Epidemiology of Hepatitis B, C, and D Viruses in Northwest Russia: A Population-Based Cross-Sectional Study. Viruses, 18(6), 632. https://doi.org/10.3390/v18060632

Vancouver

Popova AY, Ostankova YV, Olkhovskaya AY, Petrova OA, Shchemelev AN, Serikova EN, et al. Serological and Molecular Epidemiology of Hepatitis B, C, and D Viruses in Northwest Russia: A Population-Based Cross-Sectional Study. Viruses. 2026;18(6):632. doi:10.3390/v18060632

BibTeX
@article{Popova2026,
  author = {Popova, Anna Y and Ostankova, Yulia V and Olkhovskaya, Alesia Y and Petrova, Olga A and Shchemelev, Alexandr N and Serikova, Elena N and Egorova, Svetlana A and Reingardt, Diana E and Drozd, Irina V and Zhimbaeva, Ojuna B and Danilova, Ekaterina M and Milichkina, Angelica M and Ezhlova, Elena B and Melnikova, Albina A and Bashketova, Natalia S and Buts, Lidiya V and Ramsay, Edward S and Totolian, Areg A},
  title = {Serological and Molecular Epidemiology of Hepatitis B, C, and D Viruses in Northwest Russia: A Population-Based Cross-Sectional Study},
  journal = {Viruses},
  year = {2026},
  volume = {18},
  number = {6},
  pages = {632},
  doi = {10.3390/v18060632}
}
Kostenlos starten →